Courtney Delacruz
Family · Orlando, FLNPI 1588278899
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 231 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 41 manufacturers, the largest accounting for just 10.4% — the pattern of someone who eats at a lot of different presentations. Among family clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 231 payments — averaging $24.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axsome Therapeutics, Inc.$581
- Avadel CNS Pharmaceuticals, LLC$548
- Acadia Pharmaceuticals Inc$545
- Jazz Pharmaceuticals Inc.$403
- Lilly USA, LLC$395
- Takeda Pharmaceuticals U.S.A., Inc.$249
- plus $3K from 35 others
What the payments were for
- Food & beverage$5,53199%
- Education$691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axsome Therapeutics, Inc. | 21 | $581 |
| Avadel CNS Pharmaceuticals, LLC | 16 | $548 |
| Acadia Pharmaceuticals Inc | 30 | $545 |
| Jazz Pharmaceuticals Inc. | 15 | $403 |
| Lilly USA, LLC | 18 | $395 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $249 |
| EMD Serono, Inc. | 8 | $197 |
| Novartis | 8 | $189 |
| UCB, Inc. | 8 | $175 |
| CSL Behring | 6 | $174 |
| Eisai Inc. | 6 | $174 |
| Harmony Biosciences LLC | 4 | $144 |
| Neurocrine Biosciences, Inc. | 5 | $141 |
| Vanda Pharmaceuticals Inc. | 6 | $122 |
| Sanofi | 5 | $120 |
| Biogen | 5 | $117 |
| ANI Pharmaceuticals, Inc. | 5 | $112 |
| Grifols USA, LLC | 5 | $111 |
| Genentech USA, Inc. | 5 | $109 |
| GE HealthCare | 5 | $106 |
| AbbVie | 5 | $97 |
| Amneal Pharmaceuticals LLC | 5 | $97 |
| AstraZeneca(2 entities) | 4 | $91 |
| Merz Pharmaceuticals, LLC | 4 | $90 |
| Resmed Corp | 2 | $71 |
| Lundbeck LLC | 2 | $63 |
| Inspire Medical Systems, Inc. | 2 | $43 |
| Pfizer | 2 | $43 |
| Banner Life Sciences, LLC | 2 | $41 |
| Acorda Therapeutics, Inc | 2 | $30 |
| Fisher & Paykel Healthcare Inc | 1 | $27 |
| Teva Pharmaceuticals USA, Inc. | 1 | $24 |
| Amgen | 1 | $24 |
| Cycle Pharmaceuticals Inc | 1 | $24 |
| Kyowa Kirin, Inc. | 1 | $21 |
| Tanabe Pharma America, Inc. | 1 | $20 |
| Xeris Pharmaceuticals, Inc. | 1 | $19 |
| TG Therapeutics, Inc. | 1 | $18 |
| Corium, LLC | 1 | $16 |
| Merck | 1 | $16 |
| Avion Pharmaceuticals | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,601 in reported general payments places this provider in the 90th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydroxyzine Hcl | 12 | $132 |
Paid to pharmacies, not to this prescriber.
Other family in Orlando
- Donna OrtizOrlando$417K
- Lindsey McCabeOrlando$37K
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.